Floatz logo

FILGRASTIM

C-KIT Mutation

Children's Hospital of Soochow Universityprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the C-KIT Mutation cohort.

Asset / SponsorPhaseRating
Azacitidine
Children's Hospital of Soochow University
Phase 2CCC
Avapritinib
Children's Hospital of Soochow University
Phase 2CCC
Decitabine
Children's Hospital of Soochow University
Phase 2CCC
Cytosin-Arabinosid
Children's Hospital of Soochow University
Phase 2CCC
Idarubicine
Children's Hospital of Soochow University
Phase 2CCC
Dasatinib
Institute of Hematology & Blood Diseases Hospital, China
Phase 1CC

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →